Maurizi-Balzan Jocelyne, Jouve Thomas, Naciri-Bennani Hamza, Noble Johan, Tanoukhi Khadija, Motte Lionel, Malvezzi Paolo, Rostaing Lionel
Service de Néphrologie Hémodialyse Aphérèses et Transplantation rénale, CHU de Grenoble-Alpes, CS 10217, 38043 Grenoble cedex 09, France.
Service de Néphrologie Hémodialyse Aphérèses et Transplantation rénale, CHU de Grenoble-Alpes, CS 10217, 38043 Grenoble cedex 09, France.
Nephrol Ther. 2019 Nov;15(6):439-447. doi: 10.1016/j.nephro.2019.01.005. Epub 2019 Oct 1.
Many apheresis techniques can be performed in a blood-bank facility or a hemodialysis (HD) facility. However, it makes sense to perform apheresis in a hemodialysis facility as apheresis involves extra-corporeal circuits and because HD can be performed at the same time as apheresis (tandem procedure). Apheresis techniques comprise therapeutic plasma exchange, double-filtration plasmapheresis, and its derivative (rheopheresis and LDL-apheresis), and immunoadsorption (specific and semi-specific). We have setup an apheresis platform in our hospital that fulfills health recommendations. This process has involved financial investment and significant human resources, and has enabled us to network with different specialties (neurology, hematology, vascular medicine). We have setup protocols according to the type of pathology to be treated by apheresis, and to monitor clinical and biological data for each apheresis session. The main side effects of apheresis are a fall in blood pressure when a session is initiated, an increase in fluid overload, hypocalcemia, and the loss of some essential plasmatic factors. However, these side-effects are easily identified and can be properly managed in real time. Within two-years, we have performed 1845 apheresis sessions (134 patients). Of these, 66 received apheresis before and/or after kidney transplantation for ABO and/or HLA incompatibility (desensitization), for humoral rejection, or in the setting of relapsing focal-segmental glomerulosclerosis. Our patients' outcomes have been similar to those reported in the literature. The other 68 patients had various conditions. Because our program is now well-established, we are currently forming a specialist center to train physicians and nurses in the various apheresis techniques/procedures.
许多血液分离技术可在血库设施或血液透析(HD)设施中进行。然而,在血液透析设施中进行血液分离是合理的,因为血液分离涉及体外循环,而且血液透析可与血液分离同时进行(串联操作)。血液分离技术包括治疗性血浆置换、双重滤过血浆置换及其衍生技术(血液流变滤过和低密度脂蛋白分离)以及免疫吸附(特异性和半特异性)。我们在医院建立了一个符合健康建议的血液分离平台。这个过程涉及资金投入和大量人力资源,使我们能够与不同专业(神经科、血液科、血管医学)建立联系。我们根据要通过血液分离治疗的病理类型制定了方案,并对每次血液分离治疗的临床和生物学数据进行监测。血液分离的主要副作用是开始治疗时血压下降、液体超负荷增加、低钙血症以及一些必需血浆因子的丢失。然而,这些副作用很容易识别,并且可以实时妥善处理。在两年内,我们进行了1845次血液分离治疗(134名患者)。其中,66名患者因ABO和/或HLA不相容(脱敏)、体液排斥或在复发性局灶节段性肾小球硬化的情况下,在肾移植前后接受了血液分离治疗。我们患者的治疗结果与文献报道的相似。另外68名患者患有各种疾病。由于我们的项目现在已经成熟,我们目前正在组建一个专业中心,对医生和护士进行各种血液分离技术/操作的培训。